Track 1: Human Genetic Engineering

Human Genetics Engineering  is one aspect of study of the overall field of Human Biotechnology. It involves the direct manipulation of the human genome using molecular engineering tools. Recently developed methods of modification is known as gene editing. There are two types of modification : Somatic Genetic Modification and Germline Genetic Modification.

Somatic genetic modifications is about addition, cutting or changing the genes in some of the cells of an existing person, to typically alleviate any medical condition. this form of gene therapy techniques are approaching clinical practice but only for few conditions and at a high cost. This track deals with the methods and procedures and ideas regarding the modification of the human genome.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 2: Gene Therapy and Genetic Counseling

Gene therapy is an experimental technique that uses genes or simply nucleic acid polymers to treat or prevent disease into a patient's cell as a drug for disease treatment.  In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.Gene therapy is a way to fix a genetic problem at its core or source. The polymers are either translated into proteins which interfere with the target gene expression or else they could possibly correct genetic mutations.

The most common form of gene delivery is in the form of DNA that encodes the functional therapeutic gene to replace the target mutated gene. the polymer molecules are packaged inside a vector which  carries the molecules inside and helps in their integration. Gene therapy is a very effective but debatable form of treatment of genetic disorders depending upon their extent of viability and social and ethical acceptance.

Genetic counseling is the process by whixch an individual or individuals at risk of any inherited disorders are advised and made aware of the consequences and nature of the disorder , as well as te probability of developing or transmitting it.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

2nd International Conference on Molecular Biology , London, UK , June 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference on Integrative Biology, London, UK, June 19-21, 2017; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 9th International Conference on Genomics and Pharmacogenomics, London, UK, June15-16, 2017. 28th Annual Lorne Genomics Conference 2017 February 12-14.

Track 3: Stem Cell Research and Therapy

Clinical Genetics is the medical specialty which provides a diagnostic service and "genetic counselling" for individuals or families with, or at risk of, conditions which may have a genetic basis. Genetic disorders can affect any body system and any age group. The aim of Genetic Services is to help those affected by, or at risk of, a genetic disorder to live and reproduce as normally as possible. In addition a large number of individuals with birth defects and/or learning disabilities are referred and investigated for genetic factors. Individuals identified through childhood or pregnancy screening programmes also require genetic services. In the future, as the genetic contributions to common later-onset disorders such as diabetes and coronary heart disease are identified, genetic services may be required for those at high risk. Testing for genetic factors that affect drug prescribing will also increasingly become an important activity.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

5th International Conference on Integrative Biology June 19-21, 2017 London, UK; 9th International Conference on Genomics and Pharmacogenomics July 13-14, 2017 Chicago, USA; Conference on Synthetic Biology: Engineering, Evolution & Design (SEED), June 20-23, 2017 Hyatt Regency, Vancouver, British Columbia, Canada. 28th Annual Lorne Genomics Conference 2017 February 12-14, 2017 Mantra Lorne, Victoria, Australia. 29th Fungal Genetics conference March 14-19, 2017 Pacific Grove, CA

Track 4: Genomic Medicine & Molecular Diagnostics

The delivery of proper modernized healthcare is insured by the field of molecular diagnostics, which makes use of a collection of techniques used to analyze biological markers in the genome and proteome- the individual's genetic code and how their cells express their genes as proteins by applying molecular biology methods to medical testing.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017; Biotechnology Conferences Europe 2018 ; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; Biotechnology Conferences USA 2018; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017;Biotechnology Conferences Asia 2018; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 5: Oncogenomics and Cancer Heredity

Cancer is a genetic disorder in which the normal control of cell growth is lost. Oncogenomics or cancer genetics is now one of the fastest expanding medical specialties. At the molecular level, cancer is caused by mutation(s) in DNA, which result in aberrant cell proliferation. Most of these mutations are acquired and occur in somatic cells. However, some people inherit mutation(s) in the germ line. The mutation(s) occur in two classes of cellular genes: oncogenes and tumor suppressor genes.

Under normal conditions, tumor suppressor genesregulate cellular differentiation and suppression of proliferation. Mutations in these genes result in unchecked cellular proliferation resulting in tumors with abnormal cell cycles and tumor proliferation. The tumor suppressor genes contribute to cancer by the inactivating of loss of function mutation.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017; Biotechnology Conferences Japan 2018; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017;Biotechnology Conferences Middle East 2018; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017;Biotechnology Conferences Canada 2018; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 6: Ethical & Social Implications of Gene Editing

Many of the stem cells being studied are referred to as pluripotent, meaning they can give rise to any of the cell types in the body but they cannot give rise on their own to an entirely new body. (Only the earliest embryonic cells, which occur just after fertilization, can give rise to a whole other organism by themselves.) Other stem cells, such as the ones found in the adult body, are multipotent, meaning they can develop into a limited number of different tissue types. One of the most common stem cell treatments being studied is a procedure that extracts a few stem cells from a person's body and grows them in large quantities in the laboratory—what scientists refer to as expanding the number of stem cells. Once a sufficient number have been produced in this manner, the investigators inject them back into the patient. You could say that medicine up until now has been all about replacements. If your heart valve isn't working, you replace it with another valve, say from a pig. Withregenerative medicine, you're treating the cause and using your own cells to perform the replacement. The hope is that by regenerating the tissue, you're causing the repairs to grow so that it's like normal.

Genetic disorders may or may not be heritable, i.e., passed down from the parents' genes. In non-heritable genetic disorders, defects may be caused by new mutations or changes to the DNA

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017;Stem Cell Conferences 2018 USA; Regenerative Medicine Conferences ASIA; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017;Biotechnology Conferences Australia 2018; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 7: Molecular Cytogenetics

The research program in the Genome Integrity is focused on the exploration of the causes and effects of genomic instability, mechanisms of DNA repair and the study of DNA repair breakdown as an initiating or protective event in aging and cancers. The program will emphasize a mechanistic understanding of the pathways that maintain genomic integrity, the intersection of these pathways with normal cellular physiology and cancer and the application of these insights to the development of new therapeutic strategies. The Genome integrity has made major contributions towards a detailed understanding of DNA repair pathway selection as a primary influence on genomic stability and drug resistance/sensitivity in breast and ovarian cancers and the influential role of DNA repair proteins in the promotion of specific hematological malignancies

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

2nd International Conference on Molecular Biology , London, UK , June 22-24, 2017;Regenerative Medicine Conferences USA; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference on Integrative Biology, London, UK, June 19-21, 2017;Stem Cell Conferences; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017;Stem Cell Conferences 2018 Asia; 9th International Conference on Genomics and Pharmacogenomics, London, UK, June15-16, 2017. 28th Annual Lorne Genomics Conference 2017 February 12-14.

Track 8: Congenital Disorders

Congenital Disorder, also known as congenital disease, birth defect or anomaly  is a condition existing at or before birth regardless of cause. Of these diseases, those characterized by structural deformities are termed "congenital anomalies" and involve defects in a developing fetus. Birth defects vary widely in cause and symptoms. Any substance that causes birth defects is known as a teratogen. Some disorders can be detected before birth through prenatal diagnosis (screening).

Birth defects are present in about 3% of newborns in USA. Congenital anomalies resulted in about 632,000 deaths per year in 2013 down from 751,000 in 1990. The type with the greatest numbers of deaths are congenital heart disease (323,000), followed by neural tube defects (69,000).

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

Cell Therapy Conferences;16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada;Biotechnology Conferences Asia 2018; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; Biotechnology Conferences USA 2018; 

Track 9: Neurodevelopmental Genetics and Disorders

Congenital Disorder, also known as congenital disease, birth defect or anomaly  is a condition existing at or before birth regardless of cause. Of these diseases, those characterized by structural deformities are termed "congenital anomalies" and involve defects in a developing fetus. Birth defects vary widely in cause and symptoms. Any substance that causes birth defects is known as a teratogen. Some disorders can be detected before birth through prenatal diagnosis (screening). Birth defects are present in about 3% of newborns in USA. Congenital anomalies resulted in about 632,000 deaths per year in 2013 down from 751,000 in 1990. The type with the greatest numbers of deaths are congenital heart disease (323,000), followed by neural tube defects (69,000).

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

5th International Conference on Integrative Biology June 19-21, 2017 London, UK; 9th International Conference on Genomics and Pharmacogenomics July 13-14, 2017 Chicago, USA; Biotechnology Conferences Middle East 2018; Conference on Synthetic Biology; Engineering, Evolution & Design (SEED), June 20-23, 2017 Hyatt Regency, Vancouver, British Columbia, Canada.; Biotechnology Conferences Canada 2018; 28th Annual Lorne Genomics Conference 2017 February 12-14, 2017 Mantra Lorne, Victoria, Australia. 29th Fungal Genetics conference March 14-19, 2017 Pacific Grove, CA; Biotechnology Conferences Europe 2018.

Track 10: Clinical Epigenetics

Cytogenetic is a branch of genetics that is concerned with the study of the structure and function of the cell, especially the chromosomes. It includes routine analysis of G-banded chromosomes, other cytogenetic banding techniques, as well as molecular cytogenetics such as fluorescent in situ hybridization (FISH) and comparative genomic hybridization (CGH). Chromosomes were first observed in plant cells by Karl Wilhelm von Nägeli in 1842. Their behavior in animal (salamander) cells was described by Walther Flemming, the discoverer of mitosis, in 1882. The name was coined by another German anatomist, von Waldeyer in 1888.

The next stage took place after the development of genetics in the early 20th century, when it was appreciated that the set of chromosomes (the karyotype) was the carrier of the genes. Levitsky seems to have been the first to define the karyotype as the phenotypic appearance of the somatic chromosomes, in contrast to their genic contents. Investigation into the human karyotype took many years to settle the most basic question: how many chromosomes does a normal diploid human cell contain? In 1912, Hans von Winiwarter reported 47 chromosomes in spermatogonia and 48 in oogonia, concluding an XX/XO sex determination mechanism.  Painter in 1922 was not certain whether the diploid number of man was 46 or 48, at first favoring 46. He revised his opinion later from 46 to 48, and he correctly insisted on man having an XX/XY system. Considering their techniques, these results were quite remarkable.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017;Biotechnology Conferences Japan 2018; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; Stem Cell Conferences 2018 USA; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017; Regenerative Medicine Conferences ASIA; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017; Biotechnology Conferences Australia 2018;  International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 11: Clinical Trials and Regulatory Affairs

Transplantation is the transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function(s) in the body. When transplantation is performed between different species, e.g. animal to human, it is named xenotransplantation. Development of the field of organ and tissue transplantation has accelerated remarkably since the human major histocompatibility complex (MHC) was discovered in 1967. Matching of donor and recipient for MHC antigens has been shown to have a significant positive effect on graft acceptance. The roles of the different components of the immune system involved in the tolerance or rejection of grafts and in graft-versus-host disease have been clarified. These components include: antibodies, antigen presenting cells, helper and cytotoxic T cell subsets, immune cell surface molecules, signaling mechanisms and cytokines that they release. The development of pharmacologic and biological agents that interfere with the alloimmune response and graft rejection has had a crucial role in the success of organ transplantation Combinations of these agents work synergistically, leading to lower doses of immunosuppressive drugs and reduced toxicity. Reports of significant numbers of successful solid organ transplants include those of the kidneys, liver, heart and lung. The use of bone marrow transplantation for hematological diseases, particularly hematological malignancies and primary immunodeficiency’s, has become the treatment of choice in many of these conditions

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; Regenerative Medicine Conferences USA;  8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017; Stem Cell Conferences;  15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017;Stem Cell Conferences 2018 Asia;  2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 12: Genetics of Metabolic Disorders

Neurodevelopmental Disorders are impairments of the growth and development of the brain or central nervous system. A narrower use of the term refers to a disorder of brain function that affects emotion, learning ability, self-control and memory and that unfolds as the individual grows. The term is sometimes erroneously used as an exclusive synonym for autism and autism spectrum disorders. The development of the brain is orchestrated, tightly regulated, and genetically encoded process with clear influence from the environment. This suggests that any deviation from this program early in life can result in neurodevelopmental disorders and, depending on specific timing, might lead to distinct pathology later in life. Because of that, there are many causes of neurodevelopmental disorder, which can range from deprivation, genetic and metabolic diseases, immune disorders, infectious diseases, nutritional factors, physical trauma, and toxic and environmental factors. Some neurodevelopmental disorders—such as autism and other pervasive developmental disorders—are considered multifactorial syndromes (with many causes but more specific neurodevelopmental manifestation).

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

2nd International Conference on Molecular Biology , London, UK , June 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; Biotechnology Conferences Asia 2018;  5th International Conference on Integrative Biology, London, UK, June 19-21, 2017; Biotechnology Conferences USA 2018; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017;Biotechnology Conferences Europe 2018;   9th International Conference on Genomics and Pharmacogenomics, London, UK, June15-16, 2017. 28th Annual Lorne Genomics Conference 2017 February 12-14; Cell Therapy Conferences

Track 13: Behavioral Genetics and Evolutionary Psychology

Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects.The term Pharmacogenetics is often used interchangeably with the term pharmacogenomics which also investigates the role of acquired and inherited genetic differences in relation to drug response and drug behavior through a systematic examination of genes, gene products, and inter- and intra-individual variation in gene expression and function. In oncology, pharmacogenetics historically is the study of germ line mutations (e.g., single-nucleotidepolymorphisms affecting genes coding for liver enzymes responsible for drug deposition and pharmacokinetics), whereas pharmacogenomics refers to somatic mutations in tumoral DNA leading to alteration in drug response (e.g., KRAS mutations in patients treated with anti-Her1 biologics).

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

2nd International Conference on Molecular Biology , London, UK , June 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference on Integrative Biology, London, UK, June 19-21, 2017; Biotechnology Conferences Middle East 2018; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017;Biotechnology Conferences Europe 2018; 9th International Conference on Genomics and Pharmacogenomics, London, UK, June15-16, 2017. 28th Annual Lorne Genomics Conference 2017 February 12-14; Biotechnology Conferences Canada 2018

Track 14: Nutritional Genomics

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup. Many drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It can be difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects (called adverse drug reactions). Adverse drug reactions are a significant cause of hospitalizations and deaths in the United States. With the knowledge gained from the Human Genome Project, researchers are learning how inherited differences in genes affect the body’s response to medications. These genetic differences will be used to predict whether a medication will be effective for a particular person and to help prevent adverse drug reactions.The field of pharmacogenomics is still in its infancy. Its use is currently quite limited, but new approaches are under study in clinical trials. In the future, pharmacogenomics will allow the development of tailored drugs to treat a wide range of health problems, including cardiovascular disease, Alzheimer disease, cancer, HIV/AIDS, and asthma.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017;Biotechnology Conferences Canada 2018; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; Biotechnology Conferences Australia 2018; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017;Biotechnology Conferences Japan 2018;  International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 15: Genes and Environment

Driven by chemistry but increasingly guided by Pharmacology and the clinical sciences, Drug Research has contributed more to the progress of medicine during the past century than any other scientific factor. Improving the science of drug development and regulation is important in fulfilling the public health. The advent of molecular biology and, in particular, of genomic sciences is having a deep impact on drug discovery. Emphasis is placed on the contrast between the academic and industrial research operating environments, which can influence the effectiveness of research collaboration between the two constituencies, but which plays such an important role in drug innovation. The strategic challenges that research directors face are also emphasized.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017;Biotechnology Conferences Australia 2018; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; Regenerative Medicine Conferences ASIA; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017;Stem Cell Conferences 2018 USA;  International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Track 16: Genetic Epidemiology

Recent developments, including next-generation sequencing (NGS), bio-ontologies and the Semantic Web, and the growing role of hospital information technology (IT) systems and electronic health records, amass ever-increasing amounts of data before human genetics scientists and clinicians. However, they have ever-improving tools to analyze those data for research and clinical care. Correspondingly, the field of bioinformatics is turning to research questions in the field of human genetics, and the field of human genetics is making greater use of bioinformatic algorithms and tools. The choice of "Bioinformatics and Human Genetics" as the topic of this special issue of Human Mutation reflects this new importance of bioinformatics and medical informatics in human genetics. Experts from among the attendees of the Paris 2010 Human Variome Project symposium provide a survey of some of the "hot" computational topics over the next decade. These experts identify the promise-what human geneticists who are not themselves bioinformaticians stand to gain-as well as the challenges and unmet needs that are likely to represent fruitful areas of research.

Related Human Genetics Conferences | Genetics Conferences | Human Genetics Congress | Europe Conferences

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orland, USA, March 20-22, 2017; Regenerative Medicine Conferences USA; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017;Stem Cell Conferences 2018 Asia; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017. International Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.;  Regenerative Medicine Conferences ASIA.